MA29643B1 - Benzocycloheptapyridines comme inhibiteurs du recepteur tyrozine kinase met - Google Patents
Benzocycloheptapyridines comme inhibiteurs du recepteur tyrozine kinase metInfo
- Publication number
- MA29643B1 MA29643B1 MA30591A MA30591A MA29643B1 MA 29643 B1 MA29643 B1 MA 29643B1 MA 30591 A MA30591 A MA 30591A MA 30591 A MA30591 A MA 30591A MA 29643 B1 MA29643 B1 MA 29643B1
- Authority
- MA
- Morocco
- Prior art keywords
- tyrozine
- benzocycloheptapyridines
- receptor inhibitors
- met receptor
- kinase met
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
La présente invention concerne des dérivés de 5H-benzo[4,5]cyclohepta[1,2-b] pyridine, qui sont utiles pour le traitement des maladies de prolifération cellulaire, pour le traitement des troubles associés à l'activité MET, et pour l'inhibition du récepteur tyrosine-kinase MET. L'invention concerne aussi des compositions qui comprennent ces composés, et des procédés les utilisant pour traiter le cancer chez les mammifères.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69322905P | 2005-06-23 | 2005-06-23 | |
US72906105P | 2005-10-21 | 2005-10-21 | |
US78947306P | 2006-04-05 | 2006-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29643B1 true MA29643B1 (fr) | 2008-07-01 |
Family
ID=37595817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30591A MA29643B1 (fr) | 2005-06-23 | 2008-01-23 | Benzocycloheptapyridines comme inhibiteurs du recepteur tyrozine kinase met |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1896422B1 (fr) |
KR (1) | KR20080018907A (fr) |
AR (1) | AR057377A1 (fr) |
AT (1) | ATE520664T1 (fr) |
BR (1) | BRPI0612518A2 (fr) |
CR (1) | CR9579A (fr) |
CY (1) | CY1112038T1 (fr) |
DO (1) | DOP2006000143A (fr) |
EC (1) | ECSP078017A (fr) |
IL (1) | IL187895A0 (fr) |
MA (1) | MA29643B1 (fr) |
MX (1) | MX2007016533A (fr) |
NI (1) | NI200700318A (fr) |
NO (1) | NO20080417L (fr) |
NZ (1) | NZ563711A (fr) |
PE (1) | PE20070167A1 (fr) |
PL (1) | PL1896422T3 (fr) |
PT (1) | PT1896422E (fr) |
SI (1) | SI1896422T1 (fr) |
TW (1) | TW200738638A (fr) |
WO (1) | WO2007002258A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200813021A (en) * | 2006-07-10 | 2008-03-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
US7893081B2 (en) * | 2007-12-20 | 2011-02-22 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
CA2771338A1 (fr) | 2009-09-30 | 2011-04-07 | Merck Sharp & Dohme Corp. | Sels de chlorhydrate cristallins d'inhibiteurs de kinase c-met |
AU2010302419B2 (en) | 2009-09-30 | 2014-07-31 | Merck Sharp & Dohme (Uk) Limited | Formulations for c-Met kinase inhibitors |
WO2012003338A1 (fr) | 2010-07-01 | 2012-01-05 | Takeda Pharmaceutical Company Limited | Combinaison d'un inhibiteur de cmet et d'un anticorps dirigé contre hgf et/ou cmet |
EP3229836B1 (fr) | 2014-12-09 | 2019-11-13 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Anticoprs monoclonaux contre 'axl' |
WO2016135041A1 (fr) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Protéines de fusion et anticorps les contenant pour favoriser l'apoptose |
US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
JP2023500906A (ja) | 2019-11-08 | 2023-01-11 | インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) | キナーゼ阻害剤に対する獲得抵抗性を有するがんの処置方法 |
WO2021148581A1 (fr) | 2020-01-22 | 2021-07-29 | Onxeo | Nouvelle molécule dbait et son utilisation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2460939C (fr) * | 2001-09-19 | 2008-07-29 | Pharmacia Corporation | Composes de pyrazolyl substitues pour le traitement de l'inflammation |
AU2003230758A1 (en) * | 2002-04-02 | 2003-10-20 | Merck And Co., Inc. | 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists |
-
2006
- 2006-06-14 TW TW095121232A patent/TW200738638A/zh unknown
- 2006-06-16 AR ARP060102571A patent/AR057377A1/es not_active Application Discontinuation
- 2006-06-21 PE PE2006000702A patent/PE20070167A1/es not_active Application Discontinuation
- 2006-06-22 KR KR1020077030202A patent/KR20080018907A/ko not_active Application Discontinuation
- 2006-06-22 WO PCT/US2006/024256 patent/WO2007002258A2/fr active Application Filing
- 2006-06-22 NZ NZ563711A patent/NZ563711A/en not_active IP Right Cessation
- 2006-06-22 PL PL06785319T patent/PL1896422T3/pl unknown
- 2006-06-22 BR BRPI0612518-2A patent/BRPI0612518A2/pt not_active IP Right Cessation
- 2006-06-22 AT AT06785319T patent/ATE520664T1/de active
- 2006-06-22 EP EP06785319A patent/EP1896422B1/fr active Active
- 2006-06-22 PT PT06785319T patent/PT1896422E/pt unknown
- 2006-06-22 MX MX2007016533A patent/MX2007016533A/es unknown
- 2006-06-22 SI SI200631136T patent/SI1896422T1/sl unknown
- 2006-06-23 DO DO2006000143A patent/DOP2006000143A/es unknown
-
2007
- 2007-12-04 NI NI200700318A patent/NI200700318A/es unknown
- 2007-12-04 IL IL187895A patent/IL187895A0/en unknown
- 2007-12-07 CR CR9579A patent/CR9579A/es not_active Application Discontinuation
- 2007-12-14 EC EC2007008017A patent/ECSP078017A/es unknown
-
2008
- 2008-01-22 NO NO20080417A patent/NO20080417L/no not_active Application Discontinuation
- 2008-01-23 MA MA30591A patent/MA29643B1/fr unknown
-
2011
- 2011-11-16 CY CY20111101099T patent/CY1112038T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1112038T1 (el) | 2015-11-04 |
PL1896422T3 (pl) | 2012-01-31 |
KR20080018907A (ko) | 2008-02-28 |
PT1896422E (pt) | 2011-11-08 |
MX2007016533A (es) | 2008-03-06 |
ECSP078017A (es) | 2008-01-23 |
PE20070167A1 (es) | 2007-04-16 |
NZ563711A (en) | 2010-12-24 |
EP1896422A2 (fr) | 2008-03-12 |
SI1896422T1 (sl) | 2011-11-30 |
WO2007002258A2 (fr) | 2007-01-04 |
AR057377A1 (es) | 2007-11-28 |
TW200738638A (en) | 2007-10-16 |
WO2007002258A3 (fr) | 2007-06-07 |
NI200700318A (es) | 2008-05-23 |
IL187895A0 (en) | 2008-03-20 |
ATE520664T1 (de) | 2011-09-15 |
EP1896422B1 (fr) | 2011-08-17 |
DOP2006000143A (es) | 2007-02-28 |
BRPI0612518A2 (pt) | 2010-11-23 |
CR9579A (es) | 2008-03-06 |
NO20080417L (no) | 2008-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30631B1 (fr) | Inhibiteurs de tyrosine kinase | |
MA29643B1 (fr) | Benzocycloheptapyridines comme inhibiteurs du recepteur tyrozine kinase met | |
SI1896421T1 (sl) | Benzocikloheptapiridini kot inhibitorji receptorjev tirozin kinaze met | |
YU84603A (sh) | Novi inhibitori tirozin kinaze | |
TW200633980A (en) | Pyridones useful as inhibitors of kinases | |
MY138836A (en) | Quinoline derivatives and their use as 5-ht6 receptor ligands | |
PL1699800T3 (pl) | Bicykliczne heterocykliczne inhibitory kinazy p-38 | |
HK1113569A1 (en) | Pyrazolo | |
MA31521B1 (fr) | Dérivés de 2,3-dihydrobenzo[1,4] dioxin-2-ylméthyle utilisés en tant qu'antagonistes des alpha2c pour traiter des maladies des systèmes nerveux périphérique et central | |
MA31442B1 (fr) | 3-(imidazolyl)-pyrazolo [3,4-b]pyridines | |
MY132229A (en) | Indole derivatives as 5-ht receptor antagonist | |
WO2006124354A3 (fr) | Inhibiteurs de la tyrosine kinase | |
TW200616641A (en) | Novel piperidyl derivatives of quinazoline and isoquinoline | |
NO20061194L (no) | Mitotiske kinesininbibitorer | |
MX2010006748A (es) | Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2. | |
MX2007006754A (es) | Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos. | |
HRP20060127A2 (en) | Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist | |
MA29561B1 (fr) | DERIVES DE PYRIDO[2,3-d] PYRIMIDINE, LEUR PREPARATION, LEUR APPLICATION EN THERAPEUTIQUE | |
MXPA04010307A (es) | Derivados 5-oxo y 5-tio de 5h-indeno`1,2-bipiridina con enlace al receptor a2a de la adenosina y actividad inhibidora de la fosfodiesterasa para el tratamiento de trastornos neurodegenerativos y enfermedades relacionadas con la inflamacion. | |
WO2007050380A3 (fr) | Inhibiteurs de la tyrosine kinase | |
YU75603A (sh) | Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja | |
AU4038000A (en) | 4-substituted quinoline derivatives as gaba receptor ligands | |
GB0420831D0 (en) | Novel compounds | |
MX9701820A (es) | Compuestos de pirazolo [3,4-g] quinoxalina que inhiben proteina tirosina quinasa receptora de pdgf. | |
ATE367380T1 (de) | Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate |